A
Anuh Pharma Ltd
BSE:506260
Anuh Pharma Ltd
BSE:506260
Price:
83
INR
4.47%
Market Cap:
₹4.2B
Relative Value
The Relative Value of one ANUHPHR stock under the Base Case scenario is hidden INR. Compared to the current market price of 83 INR, Anuh Pharma Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ANUHPHR Relative Value
HIDDEN
Multiples Across Competitors
ANUHPHR Competitors Multiples
Anuh Pharma Ltd Competitors
Anuh Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
A
|
Anuh Pharma Ltd
BSE:506260
|
4.2B INR | 0.6 | 10.6 | 7.2 | 8.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD | 15.3 | 48.3 | 32.5 | 34.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF | 4.6 | 29.8 | 12.6 | 14.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF | 5.3 | 21.4 | 13.2 | 17 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP | 5.3 | 32.6 | 15.5 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.6 | 13.9 | 10.2 | 11.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 6.9 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
